1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of FABP2 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression ISO RGD:2591 6480464 1-Naphthylisothiocyanate results in increased expression of FABP2 mRNA CTD PMID:25380136 , PMID:30723492 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:2591 6480464 2 more ... CTD PMID:27291303 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP2 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of FABP2 mRNA CTD PMID:28238261 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of FABP2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FABP2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:2591 6480464 Tetrachlorodibenzodioxin results in increased expression of FABP2 mRNA CTD PMID:21215274 2,4,6-trinitrobenzenesulfonic acid decreases expression EXP 6480464 Trinitrobenzenesulfonic Acid results in decreased expression of FABP2 mRNA CTD PMID:17982090 2,4,6-trinitrotoluene affects expression ISO RGD:2591 6480464 Trinitrotoluene affects the expression of FABP2 mRNA CTD PMID:21346803 2,4-dinitrotoluene decreases expression EXP 6480464 2, 4-dinitrotoluene results in decreased expression of FABP2 mRNA CTD PMID:24893713 2,4-dinitrotoluene affects expression ISO RGD:2591 6480464 2, 4-dinitrotoluene affects the expression of FABP2 mRNA CTD PMID:21346803 4,4'-diaminodiphenylmethane increases expression ISO RGD:2591 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FABP2 mRNA CTD PMID:25380136 , PMID:30723492 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of FABP2 mRNA CTD PMID:18648102 aflatoxin M1 decreases expression ISO RGD:735842 6480464 Aflatoxin M1 results in decreased expression of FABP2 mRNA CTD PMID:30928695 ammonium chloride affects expression ISO RGD:2591 6480464 Ammonium Chloride affects the expression of FABP2 mRNA CTD PMID:16483693 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of FABP2 mRNA CTD PMID:19770486 , PMID:21715664 benzo[a]pyrene increases methylation ISO RGD:735842 6480464 Benzo(a)pyrene results in increased methylation of FABP2 5' UTR, Benzo(a)pyrene results in increased methylation of FABP2 exon CTD PMID:27901495 bexarotene multiple interactions ISO RGD:2591 6480464 [Tamoxifen co-treated with bexarotene] results in decreased expression of FABP2 mRNA CTD PMID:17630414 bexarotene decreases expression ISO RGD:2591 6480464 bexarotene results in decreased expression of FABP2 mRNA CTD PMID:17630414 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of FABP2 mRNA CTD PMID:17118139 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of FABP2 mRNA CTD PMID:19245819 , PMID:19850644 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of FABP2 mRNA CTD PMID:28085963 captan increases expression EXP 6480464 Captan results in increased expression of FABP2 mRNA CTD PMID:31558096 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25620056 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of FABP2 mRNA CTD PMID:17585979 copper(II) sulfate decreases expression ISO RGD:735842 6480464 Copper Sulfate results in decreased expression of FABP2 mRNA CTD PMID:19549813 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of FABP2 mRNA CTD PMID:19770486 decabromodiphenyl ether increases expression ISO RGD:2591 6480464 decabromobiphenyl ether results in increased expression of FABP2 mRNA CTD PMID:23640034 dichlorine multiple interactions ISO RGD:2591 6480464 [Ozone co-treated with Chlorine] results in increased expression of FABP2 mRNA CTD PMID:18636392 diclofenac decreases expression ISO RGD:2591 6480464 Diclofenac results in decreased expression of FABP2 mRNA CTD PMID:19022234 diclofenac decreases expression EXP 6480464 Diclofenac results in decreased expression of FABP2 mRNA CTD PMID:26934552 endosulfan decreases expression ISO RGD:2591 6480464 Endosulfan results in decreased expression of FABP2 mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:2591 6480464 [Fish Oils co-treated with Ethanol] results in increased expression of FABP2 mRNA CTD PMID:17347304 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of FABP2 mRNA CTD PMID:17118139 ferroheme b multiple interactions ISO RGD:2591 6480464 [Heme co-treated with Calcium, Dietary] results in increased expression of FABP2 mRNA CTD PMID:15539406 ferroheme b increases expression ISO RGD:2591 6480464 Heme results in increased expression of FABP2 mRNA CTD PMID:15539406 folpet increases expression EXP 6480464 folpet results in increased expression of FABP2 mRNA CTD PMID:31558096 furan increases expression ISO RGD:2591 6480464 furan results in increased expression of FABP2 mRNA CTD PMID:25539665 , PMID:26194646 heme b increases expression ISO RGD:2591 6480464 Heme results in increased expression of FABP2 mRNA CTD PMID:15539406 heme b multiple interactions ISO RGD:2591 6480464 [Heme co-treated with Calcium, Dietary] results in increased expression of FABP2 mRNA CTD PMID:15539406 iron atom increases expression ISO RGD:2591 6480464 Iron deficiency results in increased expression of FABP2 mRNA CTD PMID:19821111 iron(0) increases expression ISO RGD:2591 6480464 Iron deficiency results in increased expression of FABP2 mRNA CTD PMID:19821111 metformin decreases expression ISO RGD:2591 6480464 Metformin results in decreased expression of FABP2 mRNA CTD PMID:19022234 microcystin-LR increases expression EXP 6480464 cyanoginosin LR results in increased expression of FABP2 protein CTD PMID:26984711 N-methyl-4-phenylpyridinium increases expression ISO RGD:735842 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FABP2 mRNA CTD PMID:24767308 N-nitrosodiethylamine multiple interactions ISO RGD:2591 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FABP2 mRNA CTD PMID:28943392 N-nitrosodimethylamine increases expression ISO RGD:2591 6480464 Dimethylnitrosamine results in increased expression of FABP2 mRNA CTD PMID:25380136 oleic acid affects binding ISO RGD:2591 6480464 FABP2 protein modified form binds to Oleic Acid CTD PMID:16137630 ozone multiple interactions ISO RGD:2591 6480464 [Ozone co-treated with Chlorine] results in increased expression of FABP2 mRNA CTD PMID:18636392 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of FABP2 mRNA CTD PMID:17562736 perfluorohexanesulfonic acid decreases expression EXP 6480464 perfluorohexanesulfonic acid results in decreased expression of FABP2 mRNA CTD PMID:21705711 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of FABP2 mRNA CTD PMID:21705711 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of FABP2 mRNA CTD PMID:17681415 , PMID:18467677 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of FABP2 mRNA CTD PMID:30657992 perfluorooctanoic acid multiple interactions EXP 6480464 PPARA protein promotes the reaction [perfluorooctanoic acid results in increased expression of FABP2 mRNA] CTD PMID:18467677 phenobarbital increases expression ISO RGD:2591 6480464 Phenobarbital results in increased expression of FABP2 mRNA CTD PMID:19162173 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of FABP2 mRNA CTD PMID:23091169 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of FABP2 mRNA CTD PMID:25270620 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of FABP2 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of FABP2 mRNA] CTD PMID:18467677 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of FABP2 mRNA CTD PMID:16221962 more ... potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of FABP2 mRNA CTD PMID:23608068 pravastatin increases expression ISO RGD:2591 6480464 Pravastatin results in increased expression of FABP2 mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of FABP2 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:2591 6480464 Pregnenolone Carbonitrile results in increased expression of FABP2 mRNA CTD PMID:19162173 propamocarb decreases expression EXP 6480464 propamocarb results in decreased expression of FABP2 mRNA CTD PMID:29137890 propiconazole decreases expression EXP 6480464 propiconazole results in decreased expression of FABP2 mRNA CTD PMID:21278054 rifaximin multiple interactions ISO RGD:735842 6480464 [NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of FABP2 protein CTD PMID:22790967 rotenone decreases expression ISO RGD:2591 6480464 Rotenone results in decreased expression of FABP2 mRNA CTD PMID:28374803 sodium dichromate increases expression ISO RGD:2591 6480464 sodium bichromate results in increased expression of FABP2 mRNA CTD PMID:25993096 tacrolimus hydrate decreases expression EXP 6480464 Tacrolimus results in decreased expression of FABP2 mRNA CTD PMID:25270620 tamoxifen multiple interactions ISO RGD:2591 6480464 [Tamoxifen co-treated with bexarotene] results in decreased expression of FABP2 mRNA CTD PMID:17630414 tamoxifen decreases expression ISO RGD:2591 6480464 Tamoxifen results in decreased expression of FABP2 mRNA CTD PMID:17630414 tetrachloromethane decreases expression ISO RGD:2591 6480464 Carbon Tetrachloride results in decreased expression of FABP2 mRNA CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of FABP2 mRNA CTD PMID:31919559 thioacetamide increases expression ISO RGD:2591 6480464 Thioacetamide results in increased expression of FABP2 mRNA CTD PMID:23411599 , PMID:34492290 thioacetamide multiple interactions ISO RGD:2591 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of FABP2 mRNA CTD PMID:28943392 troglitazone increases expression ISO RGD:2591 6480464 troglitazone results in increased expression of FABP2 mRNA CTD PMID:19022234 valproic acid affects response to substance ISO RGD:735842 6480464 FABP2 gene SNP affects the susceptibility to Valproic Acid CTD PMID:17310796 valproic acid decreases methylation ISO RGD:735842 6480464 Valproic Acid results in decreased methylation of FABP2 gene CTD PMID:29501571 vinclozolin decreases expression ISO RGD:2591 6480464 vinclozolin results in decreased expression of FABP2 mRNA CTD PMID:23034163 zinc atom increases expression ISO RGD:2591 6480464 Zinc deficiency results in increased expression of FABP2 mRNA CTD PMID:11717422 zinc(0) increases expression ISO RGD:2591 6480464 Zinc deficiency results in increased expression of FABP2 mRNA CTD PMID:11717422